Article History
First Online: 7 March 2022
Declarations
:
: LB is the principal investigator of the MELLOW trial (NCT02615340) which is supported by grants from the University of Toronto and Canadian Critical Care Trials Group. RS received grants from the French Ministry of Health. RS is member of the scientific committee of the DEMEL trial (NCT03524937) and the principal investigator of the R2D2 trial (NCT04273360). EWE has ongoing funding from the NIH and the Veteran’s Affairs.
Free to read: This content has been made available to all.